Action:
To amend regulations pertaining to medication in racehorses.
Action 1259
General Information
| Action Summary |
The amendments adopt four new substantive provisions in Medication (11 VAC 10-180-10 et seq.). The provisions are (i) the possessing or administering Erythropietin or any analogous substance is prohibited, (ii) prohibiting the use of "shockwave therapy" devices on racehorses ten days prior to a race, (iii) treating racehorses three hours or less prior to post time, and (iv) restricting the levels of carbon dioxide concentrations in post-race testing. |
| Chapters Affected |
Only affects this chapter.
|
| Executive Branch Review |
This Action is exempt from Article 2 of the Administrative Process Act.
The normal executive branch review process is not required. As such, it can be submitted directly for publication and
is effective upon publication.
Exempt Citation:
2.2-4002 (B) (23)
|
| RIS Project |
No project yet assigned to this action |
| New Periodic Review |
This action will not be used to conduct a new periodic review.
|
Stages
Stages associated with this regulatory action.
| Stage ID |
Stage Type |
Status |
|
2229
|
Final
|
Stage complete. This regulation became effective on 03/31/2003. |
Contact Information
|
Name / Title:
|
Katreena Lewis
/
Director of Licensing and Policy
|
|
Address:
|
10700 Horsemens Road
New Kent, VA 23124
|
|
Email Address:
|
Katreena.Lewis@vrc.virginia.gov
|
|
Phone:
|
()-
FAX: ()-
TDD: ()-
|
This person is the primary contact for this agency.
